Results 111 to 120 of about 883,208 (316)

Restenosis after coronary angioplasty: An overview

Journal of the American College of Cardiology, 1991
Despite substantial basic and clinical efforts to address the problem of restenosis after percutaneous coronary intervention, effective preventive therapies have not yet been developed. Nevertheless, the accumulated information has provided much insight into the process of restenosis in addition to allowing standards to be developed for adequate ...
Califf, Robert M., Fortin, Donald F., Frid, David J., Harlan, William R., Ohman, E.Magnus, Bengtson, James R., Nelson, Charlotte L., Tcheng, James E., Mark, Daniel B., Stack, Richard S.   +9 more
openaire   +2 more sources

Liraglutide Ameliorates Injury‐Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K–mTOR Signaling Pathway

The FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Liraglutide inhibits chronic stress‐induced vascular injury in mice by inhibiting the activation of the PI3K‐mTOR signaling pathway and promoting autophagy of smooth muscle cells or macroautophagy. ABSTRACT Chronic stress is a significant risk factor for postoperative restenosis and other cardiovascular diseases, as it can promote the intimal ...
Zongyi Zhang, Guixian Wu, Chaozhi Xu, Shanqian Li, Yulin Zhang, Yue Hu, Wanhua Wu, Hongyu Ding, Yuling Liu, Yue Huang, Wenjun Lu, Meimei Zheng, Yue Zhang, Hongxian Wu, Lina Hu   +14 more
wiley   +1 more source

Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]

, 2008
In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Balázs, T., Bognár, Eszter, Dobránszky, János, Ring, Gy.   +3 more
core  

Gene Therapy for Cardiovascular Disease [PDF]

, 2003
The last decade has seen substantial advances in the development of gene therapy strategies and vector technology for the treatment of a diverse number of diseases, with a view to translating the successes observed in animal models into the clinic ...
Baker, Andrew H., Denby, Laura, Dishart, Kate L., Work, Lorraine M.   +3 more
core   +4 more sources

Experimental models of coronary artery restenosis

Journal of the American College of Cardiology, 1992
The study of potentially effective drug therapies and mechanical devices for the prevention of restenosis after percutaneous coronary revascularization has relied heavily on the use of experimental animal models. To date, greater than 50 experimental studies have been reported and have suggested that at least nine different classes of pharmacologic ...
Muller, David W.M., Ellis, Stephen G., Topol, Eric J.   +2 more
openaire   +2 more sources

Quantifying stent‐induced dose perturbations in intravascular brachytherapy using 3D‐ printed phantoms and film dosimetry

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background Coronary artery disease (CAD), the leading cause of death worldwide, is the narrowing of coronary arteries due to atherosclerotic plaque buildup. A common treatment for CAD is percutaneous coronary intervention (PCI), often involving stent placement. However, a common complication or in‐stent restenosis (ISR) can occur in 10%–20% of
Jessica S. Jung, Lyu Huang, Nicholas Coupera, Yijian Cao, Jenghwa Chang   +4 more
wiley   +1 more source

Partial CFD models of cardiovascular stents [PDF]

, 2002
Copyright @ 2002 Wiley BlackwellThis paper outlines the use of a partial CFD stent model in order to improve discretisation of important small features. The effects of mesh size on the performance measure are investigated.
Atherton, MA, Tesch, K
core  

Intentional Stent Fracture to Accommodate Growth After Coarctation Stenting in an 860‐g Neonate

Catheterization and Cardiovascular Interventions, Volume 107, Issue 1, Page 34-37, January 1, 2026.
ABSTRACT Background Congenital aortic coarctation in neonates and children can be managed with transcatheter stent implantation, but this approach raises the issue of how to accommodate the fixed stent structure within the growing vessel. Case Summary A 15‐month‐old boy, born prematurely with critical aortic coarctation, was treated at 1 week of age ...
Magdalena Cuman, Gernot Buheitel, Peter Ewert, Stanimir Georgiev   +3 more
wiley   +1 more source

Risk factors for instent restenosis of sirolimus-coated stents in coronary intervention for patients with unstable angina

Scientific Reports
To investigate the instent restenosis rate of sirolimus-coated stents in percutaneous coronary intervention (PCI) and risk factors for in-stent restenosis, patients with unstable angina (UA) caused by coronary artery stenosis were enrolled, and all ...
Dongchao Liu, Zheng Xue, Jingxian Qi, Liang Yin, Bing Duan, Lin Wu, Kun Yang, Bulang Gao, Qinying Cao, Jie Mi   +9 more
doaj   +1 more source

To Investigate the Clinical Efficacy and Potential Mechanism of Tongxinluo Capsules in Preventing Coronary Restenosis Based on Meta-Analysis and Network Pharmacology Analysis. [PDF]

Evid Based Complement Alternat Med, 2023
Wei WX, Jiang YH.
europepmc   +1 more source